03/09/2026
MCAZ participates in the Zimbabwe Pharmaceutical Industry Conference 2026
Building a resilient and sustainable pharmaceutical ecosystem requires more than increased production and investment. It requires a regulatory environment that promotes quality, safety, innovation and sustainable sector development.
The Medicines Control Authority of Zimbabwe (MCAZ) is participating in the Zimbabwe Pharmaceutical Industry Conference 2026, being held from 3–5 September 2026 at Rainbow Towers, Harare, under the theme:
“Strengthening Zimbabwe’s Pharma Ecosystem for Resilience and Sustainability.”
MCAZ is contributing to the conference through technical presentations and an exhibition, creating opportunities to share regulatory insights and engage directly with pharmaceutical-sector stakeholders.
For manufacturers, importers, distributors, healthcare professionals and other stakeholders, the conference provides an opportunity to engage with the national medicines regulator, gain insight into regulatory expectations and explore opportunities for collaboration towards a stronger pharmaceutical sector.
MCAZ’s participation underscores its commitment to contributing to a pharmaceutical ecosystem that protects public health, promotes access to quality-assured medicines and supports sustainable industry development.
Stakeholders are encouraged to visit the MCAZ exhibition stand and engage with the team.